The effect of positive airway pressure (PAP) therapy on the components of metabolic syndrome in obstructive sleep apnea (OSA)

Not Applicable

Recruiting

• Conditions: Obstructive Sleep Apnea.; A disorder characterized by cessation of breathing for short periods during sleep

• Registration Number: IRCT2017012832249N1
• Lead Sponsor: Vice chancellor for research, Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Inclusion criteria consist of adult patients with OSA and clinical indication for PAP therapy. Exclusion criteria consist of pregnancy, cardiopulmonary disorder, upper airway cancer or surgery, change or new administration of drug for hyperlipidemia, hypertension and diabetes mellitus.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: before treatment and 3 months following beginning of the treatment. Method of measurement: Sphygomanometer.;High density lipoprotein. Timepoint: before treatment and 3 months following beginning of the treatment. Method of measurement: Direct Enzymatic Colorimetric Method.;Fasting blood sugar. Timepoint: before treatment and 3 months following beginning of the treatment. Method of measurement: glucose oxidase assay.;Triglyceride. Timepoint: before treatment and 3 months following beginning of the treatment. Method of measurement: lipase peroxidase colorometric.;Abdominal Circumference. Timepoint: before treatment and 3 months following beginning of the treatment. Method of measurement: Metre.